Dr. Jack West, Swedish Cancer Institute, identifies the platinum-based chemotherapy doublet as the backbone of first-line treatment for the majority of NSCLC patients.
Platinum-Based Chemo Doublets_ Backbone for NSCLC Treatment [720p]
Advertisement